Jovenal, Divina E.

HRN: 27-35-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFTAZIDIME 1GM (VIAL)
06/23/2025
06/30/2025
IV
2g
Q8
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: